Rapport Therapeutics, Inc. business relationships
Companies named in Rapport Therapeutics, Inc.’s 10-K filed 2026-03-10, and public companies whose annual reports name Rapport Therapeutics, Inc.. Each link shows the sentence it came from. Scores are Engagemii’s AI visibility scores.
- AEO visibility
- 3.5 / 10
- AI naming
- <1 / 100 Top 73% in its category
- Agent readiness
- 35 / 100
- AI adoption
- 0 / 100
Named in Rapport Therapeutics, Inc.’s annual report 2
“In November 2023, the Company entered into a master services agreement (the "NeuroPace Agreement") with NeuroPace Inc. ("NeuroPace"), the manufacturer and distributor of the RNS system.” SEC filing
“In November 2023, we established a collaboration with NeuroPace to leverage the RNS system's data to track responses of patients receiving RAP-219 in our Phase 2a proof-of-concept trial.” SEC filing
Companies whose annual reports name Rapport Therapeutics, Inc. 1
“In November 2023, we entered into a collaboration agreement with Rapport Therapeutics, Inc., or Rapport, a clinical-stage biotechnology company, to leverage our RNS System's unique biomarker monitoring and data analysis capabilities.” SEC filing
Links are read automatically from SEC annual reports (10-K, 20-F, 40-F). In a hand check of random links, about 8 in 10 were real business relationships, so every link carries its source sentence.